The impact of enteral immunonutrition on gut microbiota in colorectal cancer and gastric cancer patients in the preoperative period—preliminary results of randomized clinical trial
Randomized clinical trial showed no significant changes in gut microbiota of colorectal and gastric cancer patients, suggesting limited effects of immunonutrition.
Key Points
MAIN FINDING: Immunonutrition did not significantly alter gut microbiota in colorectal and gastric cancer patients before surgery.
KEY EVIDENCE: Statistical analysis showed no significant differences in alpha diversity indices between dietary groups.
APPROACH: Fourteen patients received either immunonutrition or standard products for seven days before surgery.
SIGNIFICANCE: Understanding immunonutrition's role in gut microbiota may inform nutritional support in cancer care.
Cite This Study
Kaźmierczak-Siedlecka et al. (2025) studied this question.